baber/WOPTO huggingface dataset:
Patent NZ-597450-A (NZ)
Title: Signal and devices for wired networks
Inventor: BURNS DANNY
IPC: G08B25/04
Filed: 2010-06-30
Abstract: 597450 Disclosed is an electronic device configured for communication with other electronic devices over a wired fire detection network of electronic devices such that the network is configured to transmit and/or receive a signal. The received signal includes a base voltage, for conveying power to the electronic devices, a pulsed voltage signal bearing coded information for transfer between the electronic devices and a digital signal which is superimposed onto selected portions of the pulsed voltage signal. The digital signal has a carrier signal modulated by a digital encoded data signal for transfer between the electronic devices. The digital encoded data signal represents an original digital data signal encoded in accordance with a code scheme that ensures that there is at least one transition, between high and low binary values, between every data bit of the data signal. The device can be a sounder, a loudspeaker, a fire detector or a voice communications terminal, and also includes means for generating and/or for processing the signal and means for drawing operating power from that signal.
Patent NZ-598273-A (NZ)
Title: Enhanced multiplexing for single rlc entity
Inventor: SCHLIWA-BERTLING PAUL
IPC: H04L12/46
Filed: 2010-08-25
Abstract: 598273 Disclosed is a method of transmitting data packets from a transmitter to a receiver within the context of a single radio link control "RLC entity" using indications of packet priority. The method includes transmitting lower priority data blocks containing data segments of a first higher layer packet associated with a lower priority first packet flow context "PFC" uniquely identified by a first temporary flow identifier "TFI". The method also includes interrupting the transmission of the first higher layer packet before transmission is complete and transmitting higher priority data blocks containing data segments of a second higher layer packet associated with a higher priority second PFC. The method further includes indicating the interruption by including a second TFI uniquely associated with the second PFC in an initial one of the higher priority data blocks. Transmission of the first higher layer packet is resumed after transmission of a final data segment of the second higher layer packet.
Patent NZ-600254-A (NZ)
Title: Arranging interaction and back pressure chambers for microfluidization
Inventor: RUECKL HARALD
IPC: B01F23/00
Filed: 2010-12-03
Abstract: 600254 A method for the manufacture of an oil and water emulsion is disclosed. The method comprises passing a first emulsion through a microfluidisation device to form a second emulsion, thereby reducing the average oil droplet size, and then filtering the second emulsion. The microfluidisation device comprises an interaction chamber (as pictured in figure 4), which may be of Z-type geometry, connected in fluid communication with a back pressure chamber (not pictured), which is located downstream of the interaction chamber. The interaction chamber comprises a plurality of channels (32). When an input emulsion enters the interaction chamber it is split into a plurality of sub-streams, via the channels, and then recombined (at 31), thereby reducing the emulsion's average oil droplet size. During the fluid flow through the interaction chamber the fluid pressure drops (from P1 to P2). The back pressure chamber is of a similar construction to the interaction chamber, comprising one or more channels. During the fluid flow through the back pressure chamber the average oil droplet size is further reduced and fluid pressure is also further dropped, wherein the rate of fluid pressure drop is decelerated. The slower fluid pressure decrease may lead to an increase in product stability because there is less gas enclosed in the emulsion. The further reduction of average oil droplet size through the back pressure chamber may also provide improved filtration performance, wherein less content is lost during filtration due to oil droplet size being smaller.
Patent NZ-602433-A (NZ)
Title: Electronically regulated air flow including vents in external and internal wall columns
Inventor: INNES STUART MARTIN
IPC: F24F11/76
Filed: 2011-03-30
Abstract: An air cleansing system that removes the polluted air and controls the air temperature. The system may be optionally integrated with other systems including security, surveillance, smoke alarms and the like.
Patent NZ-603859-A (NZ)
Title: Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders
Inventor: CMILJANOVIC VLADIMIR
IPC: C07D403/04
Filed: 2011-04-27
Abstract: Disclosed herein are piperazinotriazine compounds of formula (I), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as inhibitors of phosphoinositide 3-kinase (PI3K). Specifically preferred compounds include: 4-(4-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-yl)morpholine; 4-(4-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-(4-(methylsuIfonyl)piperazin-1-yl)-1,3,5-triazin-2-yl)morpholine; 4-(4-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-(4-(ethylsulfonyl)piperazin-1-yl)-1,3,5-triazin-2-yl)morpholine; 1-(4-(4-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)piperazin-1-yl)prop-2-en-1-one; 2-(4-(4-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)piperazin-1-yl)ethanamine; N-(2-(4-(4-(2-(Difluoromethyl)-1H-benzo[dlimidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)piperazin-1-yl)ethyl)acrvlamide; 4-(4-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-(4-hexylpiperazin-1-yl)-1,3,5-triazin-2-yl)morpholine; 4-(4-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-(4-(2-ethoxyethyl)piperazin-1-yl)-1,3,5-triazin-2-yl)morpholine.
Patent NZ-604412-A (NZ)
Title: Vaccine and methods to reduce campylobacter infection
Inventor: HARGIS BILLY
IPC: A61K39/00
Filed: 2011-06-09
Abstract: Discloses a vector comprising a first polynucleotide sequence encoding a CjaD (Cj0113) peptide with the sequence GVSITVEGNCDEWGTDEYNQA or a fragment of 8 amino acids of said sequence. Wherein the vector is used to prevent campylobacter infection.
Patent NZ-620913-A (NZ)
Title: Method for the preparation of a heat stable oxygen carrier-containing composition facilitating beta-beta cross-linking
Inventor: BUTT KWOK CHU
IPC: A61K47/48
Filed: 2012-08-23
Abstract: An in vitro method for the preparation of a highly purified and heat stable oxygen carrier containing pharmaceutical composition is disclosed. The oxygen carrier-containing pharmaceutical composition including haemoglobin and the haemoglobin consisting essentially of non-polymeric crosslinked tetrameric haemoglobin having a beta-beta cross-linking of greater than 40% preferably greater than 50%. The method comprises a) providing a sample of mammalian whole blood including at least red blood cells and plasma. The red blood cells are then separated from the plasma in the mammalian whole blood and the red blood cells that were separated from the plasma are filtered to obtain a filtered red blood cell fraction. The filtered red blood cell fraction is washed to remove plasma protein impurities, resulting in washed red blood cells. The washed red blood cells is disrupted to create a solution comprising a lysate of disrupted red blood cells and a filtration is performed filtration to remove at least a portion of the waste retentate from the lysate. A first haemoglobin solution is extracted from the lysate and at least one purification process is performed to remove one or more of viruses, waste retentate, or protein impurities. The first haemoglobin solution is cross-linked by bis-3,5-dibromosalicyl fumarate to form crosslinked haemoglobin in an oxygenated environment. The crosslinked haemoglobin is non-polymeric crosslinked tetrameric haemoglobin having at least 40% beta-beta cross-linking. Any residual chemicals are removed from the solution and the crosslinked haemoglobin are heat treated in a deoxygenated environment to denature and precipitate any residual non-stabilized/ non-crosslinked haemoglobin, any dimeric haemoglobin and any other protein impurities such that the resulting heat stable crosslinked tetrameric haemoglobin has an undetectable concentration of dimer and consists essentially of nonpolymeric crosslinked tetrameric haemoglobin with a beta-beta cross-linking of at least 40% and an oxygen affinity greater than the oxygen affinity of native haemoglobin of the same species measured under substantially similar conditions. Optionally the resulting heat stable crosslinked haemoglobin can be cooled and N-acetyl-cysteine can be added to the cooled crosslinked haemoglobin. The precipitate is removed by a centrifugation or a filtration to form a clear solution; and the purified and heat stable crosslinked tetrameric haemoglobin is added to a pharmaceutically acceptable carrier.
Patent NZ-624197-A (NZ)
Title: Fumigant compositions and methods
Inventor: POSS ANDREW J
IPC: A01P17/00
Filed: 2012-10-29
Abstract: Disclosed is a method of eradicating undesirable species such as weeds, nematodes, pathogens, animals and insects with fumigant compositions comprising an alkylene fluorocarbon including at least one C=CF2 group such as hexafluoropropene or 1,1,3,3,3-pentafluoropropene. Also disclosed are compositions of hexafluoropropene or 1,1,3,3,3-pentafluoropropene and at least one component selected from methyl iodide, chloropicrin, acrolein, 1,3-dichloropropene, dimethyl disulfide, furfural, propylene oxide metham sodium and combinations, and at least one surfactant. The fumigant compositions also have low toxicity and low Global Warming Potential.
Patent NZ-625147-A (NZ)
Title: Repair method for road surfacings, in particular for open-pored asphalts
Inventor: LANGE MARTIN
IPC: E01C11/00
Filed: 2012-11-23
Abstract: The present disclosure relates to a method for repairing the surface layers for roads, paths and other traffic areas, in which a polymeric material is applied in an amount of at least 20 g/m2 to the damaged place, a first polyurethane reaction mixture (can contain additives) is applied in an amount of at least 80 g/m2 to the polymeric material and a mixture containing mineral aggregate and a second polyurethane reaction mixture is applied to the first polyurethane mixture and allowed to cure. The present disclosure further relates to a repair kit for repairing surface layers for roads, paths and other traffic areas.
Patent NZ-712066-A (NZ)
Title: Interleukin-2 muteins for the expansion of t-regulatory cells
Inventor: KANNAN GUNASEKARAN
IPC: C07K14/55
Filed: 2014-03-14
Abstract: Provided herein are IL-2 muteins and IL-2 mutein Fc-fusion molecules that preferentially expand and activate T regulatory cells and are amenable to large scale production. In particular, the present invention relates to a IL-2 mutein comprising V91K substitution. Also provided herein are variant human IgG1 Fc molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also, provided herein are linker peptides that are glycosylated when expressed in mammalian cells.
Patent NZ-712156-A (NZ)
Title: Neuroactive steroids, compositions, and uses thereof
Inventor: REDDY KIRAN
IPC: C07J9/00
Filed: 2014-03-13
Abstract: Provided are methods of evaluating or treating a patient, e.g., a patient having a disorder described herein, comprising: a) optionally, acquiring a patient sample; b) acquiring an evaluation of and/or evaluating the sample for an alteration in the level 24(S)- hydroxycholesterol compared to a reference standard; and c) administering a compound of formula (I-w).
Patent NZ-715006-A (NZ)
Title: Novel glp-1 receptor modulators
Inventor: BOEHM MARCUS
IPC: C07D403/12
Filed: 2014-06-11
Abstract: Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “(Ⅰ)” represents either or both the R and S form of the compound): where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.
Patent NZ-752540-A (NZ)
Title: Antimicrobial compounds or precursors thereof comprising one or more cationic centers and a coating-incorporation group
Inventor: CHAUDHARY HARSHITA
IPC: C07D211/58
Filed: 2017-04-19
Abstract: The present disclosure describes monomeric compounds and polymeric compounds that comprise at least one of the monomeric compounds and compositions that can be included in a coating composition for coating a substrate. The coated substrate may have biocidal activity or the potential for increased biocidal activity. The potential for increased biocidal activity may be realized by exposing the coated substrate to one or more further agents, such as one or more halogens. The monomer compound comprises (i) one or more cationic centers, (ii) an N-halamine precursor group, and (iii) at least one coating-incorporation group (CIG). The CIG bonds with another component within the coating composition or alternatively the CIG may bond with a component of the substrate. The CIG of the composition may incorporate the monomer into the coating composition, may incorporate the coating composition onto the substrate, or the CIG may perform both functions.
Patent NZ-754739-A (NZ)
Title: Compositions and methods for treating alpha-1 antitrypsin deficiency
Inventor: STRAPPS WALTER
IPC: C12N15/113
Filed: 2017-12-21
Abstract: Compositions and methods for introducing double-stranded breaks within the SERPINA1 gene are provided. The compositions comprise guide RNA targeting exons of the SERPINA1 gene, and the guide RNA may be associated with a lipid nanoparticle. Compositions and methods for reducing and eliminating mutant forms of α1-antitrypsin (AAT), such as seen in subjects having α1-antitrypsin deficiency (AATD), are provided.
Patent NZ-760825-A (NZ)
Title: Method and apparatus to extract products from heat treatment process
Inventor: HALONEN ARTO
IPC: B01D53/00
Filed: 2018-06-27
Abstract: The present invention relates to a method for treating a vent gas steam from heat treatment of plant biomass. The invention also relates to an apparatus for performing the method for treating a vent gas steam from heat treatment of plant biomass. The apparatus comprises a heat treatment chamber, a series of condensers, an exhaust tube to direct the vent gas steam from the heat treatment chamber to the first condenser and wherein the apparatus is configured to perform a non-carbonizing heat treatment process. The benefits of this system is to separate the valuable components out of the vent gas steam and dispose of any harmful material.
Patent PT-100387-A (PT)
Inventor: FULGENCIO POWELL M
IPC: A01N25/00
Filed: 1992-04-15
Abstract: A solid, non-hygroscopic salt of the Formula (I)   C1 to C4 alkyl-amino or an amino-alkyl group containing a primary or a secondary amino group; and B is ammonium ion or an alkyl-substituted ammonium ion, which is substantially free of a diammonium salt    <IMAGE>  V
Patent PT-101240-A (PT)
Title: Titanium oxide-pigmented aq. coating compsns. with improved opacity - obtd. by incorporating pref. hard polymeric latex particles contg. specified acidic gps. e.g. acid phosphate ester
Inventor: VOGEL MARTIN
IPC: C09D119/02
Filed: 1993-03-26
Abstract: An aq. dispersion of TiO2 pigment particles is mixed with an aq. dispersion or suspension of polymeric latex particles (I) prepd. by emulsion polymerisation of a monomer mixt. including at least one polymerisable ethylenically unsatd. monomer selected from mono- and polybasic monomers having acidic functional gps. including at least one proton with pKa 4-8 (pref. about 6). Pref. the monomers are selected from (1) a mixt. contg. one or more ethylenically unsatd. acid-functional monomers selected from the phosphoric acid mono- and diesters of 2-hydroxyethyl and 3-hydroxypropyl methacrylates, dihydrogen vinyl-benzyl phosphates and CH2=C(CH3)COOCH2Y where Y = -CH2OPO(OH)2, -CH2CH2OPO(OH)2, -CHOHCH2OPO(OH)2 or -CH(OPO(OH)2)CH2, (2) monomers including more than 1 wt.% itaconic acid and (3) monomers including at least one unsatd. acid-functional monomer, the total wt. of which comprises at least 10 wt.% of latex solids. Opt. an aq. dispersion of polymeric latex binder particles may also be mixed in. Also claimed are the aq. pigment slurries themselves and coating compsns. derived therefrom.
Patent PT-101593-A (PT)
Title: Process for the preparation of an extruded product rich in dietary fibres, and product obtained by this process
Inventor: AMARAL-COLLACO MARIA TERESA
IPC: A23P1/12
Filed: 1994-10-20
Abstract: The invention relates to a process for the preparation of a new product made up of an extruded mixture of a component or components rich in fibres suitable for dietary purposes, obtained from surpluses or wastes from the food industries or agricultural industries, for example tomato pomace or pea pods, modified by a pre-treatment which can include grinding and, if necessary, washing with agents that improve the properties thereof, with a starchy food component or components, for example derivatives of cereals, legumes, fruits or other plants, especially chestnut and/or maize, characterized by including a set of operations linked in such a way as to constitute a logical sequence suitable for the processing of the raw materials which make up the mixture, including pre-treatment operations on each of the components, a mixing operation and an extrusion operation, resulting in a product rich in dietary fibres and with characteristics advantageous for use in food and/or dietetic products.  The starchy component can also be previously subjected to grinding and, if necessary, other prior operations. The invention also relates to the product obtained by the process of the invention, made up of an extruded mixture of a component or components rich in dietary fibres obtained from surpluses or wastes from the food industries or agricultural industries, for example tomato pomace or pea pods, and a starchy food component or components, such as, for example derivatives of cereals, legumes, fruits or other plants, especially chestnut and/or maize, the components being subjected to the process of the invention, including pre-treatment operations on each of the components, a mixing operation and an extrusion operation, resulting in a product rich in dietary fibres and with characteristics advantageous for use in food and/or dietetic products.
Patent PT-115105-A (PT)
Title: Processo para produção e funcionalização de produtos com capacidade de repelente
Inventor: FILIPA DANIELA PEREIRA FERNANDES
IPC: A01N65/44
Filed: 2018-10-25
Abstract: O INVENTO REFERE-SE A UM PROCESSO PARA PRODUÇÃO E FUNCIONALIZAÇÃO DE PRODUTOS COM CAPACIDADE DE REPELENTE DE MOSQUITOS E CONSEQUÊNCIAS INERENTES, CONCRETIZÁVEL EM VÁRIAS SOLUÇÕES, COMO A PRODUÇÃO DE PULSEIRAS ANTI MOSQUITO (ATRAVÉS DA TÉCNICA E VAZAMENTO) E A FUNCIONALIZAÇÃO DE TÊXTEIS POR ESTAMPAGEM. O PROCESSO INCLUI UMA MATRIZ PADRÃO - UMA MATRIZ NO ESTADO LÍQUIDO DE SILICONE -, SENDO O COMPOSTO INTERIOR CONSTITUÍDO POR UMA MATRIZ EM ESTADO SÓLIDO DE PARAFINA E CITRONELA, VARIANDO A PERCENTAGEM DE CADA COMPOSTO ENTRE 2%-10% EM PESO DE PARAFINA E CITRONELA EM RELAÇÃO AO SILICONE. NO CASO DO PROCESSO DE FUNCIONALIZAÇÃO DOS TÊXTEIS, É NECESSÁRIA A ADIÇÃO ÀS MATRIZES ANTERIORES MENCIONADAS DE UM AGENTE RETARDANTE, CUJA PERCENTAGEM VARIA ENTRE 0,1% E 0,7% EM PESO DO RETARDANTE EM RELAÇÃO AO SILICONE. O INVENTO É APLICÁVEL NA INDÚSTRIA DOS REPELENTES.
Patent RU-94017766-A (RU)
Inventor: ROJTERSHTEJN S S
IPC: G01R23/02
Filed: 1994-05-11
Abstract: FIELD: pulse technique. SUBSTANCE: device has speed-to-signal converter, pulse length selector, threshold element, power amplifier, and display. Device is provided with storage components, logic units, and monitored speed setting element interconnected and connected to other components of device in specific manner. EFFECT: improved precision and speed of device.
Patent RU-94018915-A (RU)
Inventor: ALIEV Z M
IPC: C25B1/22
Filed: 1994-05-25
Abstract: FIELD: chemical technology. SUBSTANCE: method involves the electrochemical oxidation of molecular chlorine under pressure. Electrolysis is carried out without diaphragm under increased oxygen pressure using porous graphite as cathode. Under these conditions the process of gaseous hydrogen evolution on cathode is changed for chlorine reduction process to hydrochloric acid and that of oxygen to water. As a result, cathode potential is decreased. EFFECT: significant decreased energy consumption.
Patent RU-94021684-A (RU)
Inventor: TIKHONOV A V
IPC: A61K38/22
Filed: 1994-06-27
Abstract: FIELD: medicine, oncology. SUBSTANCE: doxorubicin-estron is synthesized by chemical method and dissolved in hydrophobic solvent Lipiodol Ultrafluid. Preparation solution is injected to patients with primary liver cancer by intraarterial route. EFFECT: enhanced cytotoxic activity, prolonged spanlife and remission time at postoperative period.
Patent RU-94023172-A (RU)
Inventor: KRIVOROTOV A S
IPC: F02N19/02
Filed: 1994-06-16
Abstract: FIELD: mechanical engineering; engine starting devices. SUBSTANCE: invention relates to engine starting by means of additional device made in the form of cylinder liner made of ceramics with copper wire or tape located in its layer for use as electric heater, or cylinder liner made of cast iron in two layers with electric heater in the form of porcelain insulators fitted on copper wire placed inbetween. Electric motor is switched on from driver's cab by means of power switch. EFFECT: increased service life of storage battery, cut down time taken for starting.
Patent RU-94028940-A (RU)
Inventor: SAMUS N M
IPC: C07F11/00
Filed: 1994-08-02
Abstract: FIELD: chemical industry. SUBSTANCE: claimed invention describes novel coordination compounds containing atoms of copper, barium and one of rare earth elements (REE) at Cu-Ba: REE ratio of 4:2:1 and N-bis(salicylidene) semicarbazide as chelating ligand. Polynuclear N, N- bis(salicylidene)isosemicarbozidates containing atoms of copper, barium and one of rare earth elements are synthesized at 4:2:1 ratio of general formula:. They are prepared by reacting di[N, N- bis(salicylidene)isosemicarbazidato] cuprata (II), barium and REE hydroxide (REE include Y, La, Sm, Dy, Yb used in 2:1 ratio in admixture of chloroform with ethanol (10:1) when heating (40-50 C) under constant stirring for 1.5-2 hours. The technical result of the claimed invention is to create new group of polynuclear heterometallic coordination compounds containing atoms of copper, barium and one of REE at 4:2:1 ratio and bis-(salicylidene) semicarbazide as chelating ligand. These compounds may be used as starting products for preparation of polycrystalline ceramics of high-temperature superconducting materials of perovskite structure. EFFECT: improved properties of the superconducting materials. 2 cl, 3 tbl
Patent RU-94035332-A (RU)
Inventor: CHERNYSHOV A A
IPC: G01T1/20
Filed: 1994-09-22
Abstract: FIELD: production of polycrystalline plates. SUBSTANCE: method involves heating crystalline blank to temperature of 0.5 T<T <Tof basic material; effectuating thermomechanical deformation through uniaxial compression by shaped surface till plate thickness reaches double value as compared to basic blank thickness; cooling; repeatedly deforming blank by plane-parallel surface to obtain predetermined thickness of plate. EFFECT: reduced material consumption, provision for utilizing material with cracks and chips, reduced power consumption and decreased labor intensity. 2 cl, 1 dwg, 1 tbl